These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23600144)

  • 1. [Effects of pomegranate flowers polyphenols on liver PON expression of diabetes combining non-alcoholic fat liver diseases rats].
    Wei YY; Yan D; Japar A; Qu SS; Haji AA; Parhat K
    Yao Xue Xue Bao; 2013 Jan; 48(1):71-6. PubMed ID: 23600144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
    Zheng LY; Pan JQ; Lv JH
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic expression of hepatic thioredoxin mRNA in rats with non-alcoholic fatty liver disease.
    Duan XY; Zhao HP; Fan JG
    J Dig Dis; 2010 Apr; 11(2):94-100. PubMed ID: 20402835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
    Qin R; Zhang J; Li C; Zhang X; Xiong A; Huang F; Yin Z; Li K; Qin W; Chen M; Zhang S; Liang L; Zhang H; Nie H; Ye W
    Arch Pharm Res; 2012 Jul; 35(7):1241-50. PubMed ID: 22864747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
    Hong XZ; Li LD; Wu LM
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model.
    Yalniz M; Bahcecioglu IH; Kuzu N; Poyrazoglu OK; Bulmus O; Celebi S; Ustundag B; Ozercan IH; Sahin K
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2009-14. PubMed ID: 17914984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study on treating hyperlipidemic fatty liver with Taizhi'an capsule].
    Sun M; Shan JZ; Zhang GP; Ying HZ
    Zhongguo Zhong Yao Za Zhi; 2007 Apr; 32(7):616-9. PubMed ID: 17583205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease.
    Hong X; Tang H; Wu L; Li L
    J Pharm Pharmacol; 2006 Oct; 58(10):1391-8. PubMed ID: 17034663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research on therapeutic effect of yangganjiejiu prescription on alcoholic fatty liver and its mechanism].
    Chen JW; Liu D; Xue ZY; Chen B; Zhou Y; Chen SR
    Zhong Yao Cai; 2014 Feb; 37(2):293-8. PubMed ID: 25095354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats.
    Zhao JS; Zhu FS; Liu S; Yang CQ; Chen XM
    Chin Med J (Engl); 2012 Jul; 125(13):2316-21. PubMed ID: 22882855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive effects of total flavonoids of Litsea coreana leve on hepatic steatosis in rats fed with high fat diet.
    Wang JQ; Li J; Zou YH; Cheng WM; Lu C; Zhang L; Ge JF; Huang C; Jin Y; Lv XW; Hu CM; Liu LP
    J Ethnopharmacol; 2009 Jan; 121(1):54-60. PubMed ID: 18977425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of soothing liver and invigorating spleen recipes on the mRNA and protein expression of TLR4 in hepatic tissues of rats with NASH].
    Yang QH; Huang J; Zhang YP; Wang Q; He XM; Feng GF; Wang WJ; Li ZH
    Zhong Yao Cai; 2013 Jan; 36(1):78-84. PubMed ID: 23750414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of ursolic acid on liver injury and its possible mechanism in diabetes mellitus mice].
    Wang XT; Chen SS; Qi MY
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Feb; 34(2):134-136. PubMed ID: 29926677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of JNK signal transduction pathway in nonalcoholic fatty liver disease].
    Tan Y; Zhang JN; Chen JH; Wang LJ; Liu HX
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):821-5. PubMed ID: 19958640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of rutin treatment on biochemical alterations in experimental diabetes.
    Fernandes AA; Novelli EL; Okoshi K; Okoshi MP; Di Muzio BP; Guimarães JF; Fernandes Junior A
    Biomed Pharmacother; 2010 Mar; 64(3):214-9. PubMed ID: 19932588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of soothing liver and invigorating spleen recipes on SREBP-1c mRNA and protein expression in hepatic tissues of rats with non-alcoholic fatty liver disease].
    He XM; Yang QH; Li PF; Chen Z; Feng GF; Wang WJ; Liu HT; Zhang YP; Ji GY
    Zhong Yao Cai; 2011 Jun; 34(6):931-7. PubMed ID: 22017010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protecting actions of Peristrophe roxburghiane on liver functions and structure in fatty liver rats caused by insulin resistance].
    Liu YL; Lü JH
    Zhongguo Zhong Yao Za Zhi; 2007 May; 32(10):940-3. PubMed ID: 17655153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of two different extracts of total saponins from Cicer arietinum on kidney of T2DM rats].
    Kaiser A; Wei YY; Li X; Yan D; Haji AA; Parhat K
    Yao Xue Xue Bao; 2012 Apr; 47(4):541-5. PubMed ID: 22799041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin.
    Samy W; Hassanian MA
    Arab J Gastroenterol; 2011 Jun; 12(2):80-5. PubMed ID: 21684478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental research on prevention and treatment of fatty liver rats with Abrus cantoniensis].
    Zhang Q; Cai HB; Mo ZX; Shi J; Sun XG; Peng QX; Yang MH
    Zhong Yao Cai; 2012 Sep; 35(9):1450-5. PubMed ID: 23451501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.